EC Number   |
Title |
Organism |
|---|
    4.1.3.36 | Ligand-dependent active-site closure revealed in the crystal structure of Mycobacterium tuberculosis MenB complexed with product analogues |
Mycobacterium tuberculosis |
| 4.1.3.36 | Ligand-dependent active-site closure revealed in the crystal structure of Mycobacterium tuberculosis MenB complexed with product analogues |
Mycobacterium tuberculosis H37Rv |
| 4.1.3.36 | RepTB a gene ontology based drug repurposing approach for tuberculosis |
Mycobacterium tuberculosis |
| 4.1.3.36 | 4-(2'-Carboxyphenyl)-4-oxobutyryl coenzyme A ester, an intermediate in vitamin K2 (menaquinone) biosynthesis |
Escherichia coli |
| 4.1.3.36 | 4-(2'-Carboxyphenyl)-4-oxobutyryl coenzyme A ester, an intermediate in vitamin K2 (menaquinone) biosynthesis |
Galium mollugo |
| 4.1.3.36 | 4-(2'-Carboxyphenyl)-4-oxobutyryl coenzyme A ester, an intermediate in vitamin K2 (menaquinone) biosynthesis |
Mycolicibacterium phlei |
| 4.1.3.36 | Active site binding and catalytic role of bicarbonate in 1,4-dihydroxy-2-naphthoyl coenzyme a synthases from vitamin K biosynthetic pathways |
Escherichia coli |
| 4.1.3.36 | Active site binding and catalytic role of bicarbonate in 1,4-dihydroxy-2-naphthoyl coenzyme a synthases from vitamin K biosynthetic pathways |
Synechocystis sp. |
| 4.1.3.36 | Cloning, expression, purification, crystallization and preliminary X-ray crystallographic study of DHNA synthetase from Geobacillus kaustophilus |
Geobacillus kaustophilus |
| 4.1.3.36 | CoA adducts of 4-oxo-4-phenylbut-2-enoates: inhibitors of MenB from the M. tuberculosis menaquinone biosynthesis pathway |
Mycobacterium tuberculosis |
